mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.02 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.02 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.02 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.02 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.02 |